scispace - formally typeset
Z

Ze Xiong

Researcher at Zhejiang University of Technology

Publications -  9
Citations -  201

Ze Xiong is an academic researcher from Zhejiang University of Technology. The author has contributed to research in topics: Lipid metabolism & Gut flora. The author has an hindex of 5, co-authored 9 publications receiving 68 citations.

Papers
More filters
Journal ArticleDOI

Crocin-I alleviates the depression-like behaviors probably via modulating "microbiota-gut-brain" axis in mice exposed to chronic restraint stress.

TL;DR: Results suggested that crocin-I effectively alleviated depression-like behavior, likely depended on the gut microbiota and its modulation of intestinal barrier and SCFAs.
Journal ArticleDOI

Antidepressant activity of crocin-I is associated with amelioration of neuroinflammation and attenuates oxidative damage induced by corticosterone in mice.

TL;DR: It is shown that crocin-I exerts significant antidepressant effects in a model of chronic corticosterone (CORT)-induced depression, as evidenced by the attenuation of depression-like behaviors in the open field test, forced swimming test and tail suspension test.
Journal ArticleDOI

Depression-like behaviors are accompanied by disrupted mitochondrial energy metabolism in chronic corticosterone-induced mice

TL;DR: The changes of mitochondrial energy metabolism were investigated, and it was revealed that CORT condition inhibited glycolysis and fatty acid degradation pathway, and activated synthesis of triacylglycerol, leading to the reduced levels of acetyl-CoA and attenuated TCA cycle.
Journal ArticleDOI

Nicotinamide mononucleotide ameliorates the depression-like behaviors and is associated with attenuating the disruption of mitochondrial bioenergetics in depressed mice.

TL;DR: Evidence is provided for the beneficial role of NMN in energy production and suggestions that therapeutic strategies that increase the level ofNMN can be an effective treatment for depression are suggested.
Journal ArticleDOI

Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice.

TL;DR: Evaluated results indicated that oral administration of crocin-I could modify the composition of the gut microbiota and alleviate hepatic lipid disorder in mice treated with a high dose of GCs.